Aether Biomachines
Aether Biomachines, Inc. (trading as Aether Bio) is a Menlo Park, California protein engineering and advanced materials company founded in 2017 by Pavle Jeremic, which operates a proprietary robotic high-throughput screening laboratory and trains a Protein Function Model on millions of micro-scale enzyme experiments in order to discover novel proteins with novel functions. The company converts that discovery platform into physical products rather than software: the RapidPrint series of reinforced nylon 3D printing filaments and the Ultra series of carbon fiber-loaded filaments for aerospace and defense additive manufacturing, with aluminum-replacing super materials and AI-designed proteins for selective extraction of lithium, nickel and rare earth elements from low-concentration brines in development. It raised a $49M Series A in 2023 and a $15M round led by Tribe Capital in December 2025. Aether Bio runs no developer program and publishes no public API, SDK, webhook surface or machine-readable API contract on any host it operates; its platform and machine learning work is internal to the company.
Aether Biomachines is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Protein Engineering, Synthetic Biology, and Advanced Materials.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.